Imanix
IMANIX (Imatinib) is an antineoplastic (anti-cancer) drug that belongs to a class called BCR-ABL tyrosine kinase inhibitors. It is a medication used to manage and treat chronic myelogenous leukemia, gastrointestinal stromal tumors, and other malignancies.
Features
| Product Name | Imanix |
| Generic Name | Imatinib |
| Therapeutic Class | Tyrosine Kinase Inhibitor (TKI) |
| Formulation | Tablet |
| Available Pack Size | 400mg- 5x6’s, 100mg- 3x10’s |
| Available Strength | 400 mg, 100 mg |